Recent Medical Devices Acquisitions in New Jersey

Acquisition Volume in Medical Devices in New Jersey by Year

Last 5 years

Acquisition volume by year Annual acquisition counts for the last 5 years for Recent Medical Devices Acquisitions in New Jersey. 5 2022 1 2023 5 2024 3 2025 ~0 est. 0 2026
Actual Full-year estimate

M&A activity in medical devices and adjacent healthcare products shows a clear New Jersey footprint, ranging from surgical and dental technologies to sterilization, bone healing, and wearable monitoring. Across the deals below, buyers frequently position acquisitions to expand product capabilities, manufacturing capacity, and service or distribution reach.

Recent transactions also include carve-outs and platform expansion moves—such as CVC Capital Partners Fund IX acquiring the Therakos extracorporeal photopheresis business from Mallinckrodt plc, and Avista Healthcare Partners acquiring the EBI bone healing division from Highridge Medical. In parallel, multiple deals in 2023–2025 follow an “add-on to a platform” pattern, bringing new technologies or components into established medical device ecosystems.

Geographically, the listed locations cluster around New Jersey (including sites like Totowa, Branchburg, Emerson, and Mount Laurel), often complemented by broader U.S. operating footprints or global manufacturing and customer coverage.

What Stands Out

  • Add-on to an existing platform is a recurring theme, including capabilities like sterilization equipment, surgical instruments, dental components, and remote patient monitoring.
  • Carve-outs/divestitures appear in recent years, including Therakos (from Mallinckrodt) and the EBI bone healing division (from Highridge Medical).
  • Buyers investing in New Jersey tend to target specialized medical device workflows, such as benchtop blood processing, sterilization trays/cases, chlorine dioxide sterilization, and orthopedic/spinal instrumentation.
  • A consistent New Jersey operating footprint shows up across targets and facilities (for example, Emerson, Branchburg, Totowa, and Mount Laurel).
Buyer (recurring) What they often add Examples in NJ
Aterian Investment Partners Platform adds in device/sterilization ClorDiSys Solutions
ARCH Medical Solutions Corp. (Jordan Company) Contract manufacturing + instruments capacity gSource LLC
HuFriedyGroup Dental instrument portfolio scale SS White Dental
  • Buyer
    GSI Group Holdings, L Squared Capital Partners
    Target
    GenesisBPS
    Industry
    Medical Devices
    Type
    Addon

    GSI Group Holdings, a portfolio platform of L Squared Capital Partners, has acquired GenesisBPS, a designer and manufacturer of benchtop blood processing equipment and laboratory consumables. The add-on expands GSI Group’s capabilities in blood processing workflows and strengthens its global benchtop equipment and consumables platform.

  • Buyer
    Straits Orthopaedics (Mfg) Sdn Bhd, Quadria Capital
    Target
    Medin Technologies, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    Straits Orthopaedics (Mfg) Sdn Bhd has acquired Medin Technologies, Inc., a U.S.-based manufacturer of sterilization cases and trays that operates facilities in Totowa, New Jersey and Manchester, New Hampshire. The deal expands Straits’ product offerings and global manufacturing footprint for orthopaedic OEM customers; Straits is backed by Quadria Capital.

  • Buyer
    Avista Healthcare Partners
    Target
    EBI
    Seller
    Highridge Medical, H.I.G. Capital
    Industry
    Medical Devices

    Avista Healthcare Partners has acquired EBI, the bone healing division of Highridge Medical, marking Avista's 50th platform healthcare investment. The deal is a carve-out/divestiture from Highridge (a H.I.G. Capital portfolio company) intended to position EBI as a standalone leader in bone growth stimulation technologies.

  • Buyer
    HuFriedyGroup, Peak Rock Capital
    Target
    SS White Dental
    Industry
    Medical Devices
    Type
    Addon

    HuFriedyGroup, an affiliate of Peak Rock Capital, has acquired SS White Dental, a manufacturer of carbide and diamond burs, endodontic instruments, and lab tools for the dental industry. The acquisition is an add-on to HuFriedyGroup's existing dental products portfolio and is intended to expand product capabilities, global manufacturing scale, and distribution reach for dental professionals worldwide.

  • Buyer
    CVC Capital Partners Fund IX
    Target
    Therakos
    Seller
    Mallinckrodt plc
    Industry
    Medical Devices

    CVC Capital Partners Fund IX agreed to acquire the Therakos extracorporeal photopheresis business from Mallinckrodt plc for $925 million in a carve-out transaction. CVC said it will invest in further research, indication expansion and geographic growth of Therakos while key Therakos employees will transition with the business; Mallinckrodt will use proceeds to substantially reduce net debt.

  • Buyer
    Tommie Copper
    Target
    Profoot (footcare device division)
    Seller
    Rooftop Consumer Health (formerly Profoot)
    Industry
    Medical Devices
    Type
    Addon

    Tommie Copper, a Tengram Capital portfolio company, has acquired the footcare device division of Profoot (now Rooftop Consumer Health) in a carve-out transaction. The deal brings Profoot's footcare device portfolio into Tommie Copper's pain-management and wearable wellness lineup, expanding its product capabilities and retail reach.

  • Buyer
    Allentown, LLC, Aterian Investment Partners
    Target
    ClorDiSys Solutions, Inc.
    Industry
    Medical Devices
    Type
    Addon

    Allentown, LLC, a portfolio company of Aterian Investment Partners, has acquired ClorDiSys Solutions, Inc., a Branchburg, New Jersey-based provider of chlorine dioxide-based sterilization equipment and contract sterilization services. The deal is an add-on acquisition to Allentown's platform that expands its decontamination, disinfection and medical device sterilization capabilities for life sciences, biomedical research and adjacent medical device markets.

  • Buyer
    Pharos Capital Group, LLC
    Target
    RhythMedix
    Industry
    Medical Devices
    Type
    Buyout

    Pharos Capital Group has acquired a majority stake in RhythMedix, a Mount Laurel, New Jersey-based maker of wearable cardiac monitoring devices and related services. RhythMedix's management is reinvesting and will remain in place; Pharos plans to support growth through increased R&D, market share expansion, and add-on acquisitions to broaden remote patient monitoring capabilities.

  • Buyer
    ARCH Medical Solutions Corp., The Jordan Company (owner of ARCH Medical Solutions)
    Target
    gSource LLC
    Industry
    Medical Devices
    Type
    Addon

    ARCH Medical Solutions Corp., a Jordan Company platform, has acquired gSource LLC, a precision manufacturer of surgical instruments based in Emerson, New Jersey. The deal adds specialized contract-manufacturing capabilities and capacity for orthopedic and spinal surgical instrumentation to ARCH’s national network of FDA-registered facilities as an add-on to its platform.

  • Buyer
    AEA Investors (AEA SBPE)
    Target
    Rees Scientific, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    AEA Investors' Small Business Private Equity (AEA SBPE) has closed the acquisition of Rees Scientific, Inc., with rollover investment from the company's employees. Rees Scientific, headquartered in Trenton, New Jersey, provides automated environmental monitoring systems and a differentiated service network serving biopharma, biotech, hospitals, blood banks, academic and CRO customers.

  • Buyer
    Ra Medical Systems, Inc.
    Target
    Catheter Precision, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    Ra Medical Systems entered into a definitive agreement to acquire privately held Catheter Precision through a stock-for-stock reverse merger in which Catheter Precision will become a wholly owned subsidiary. The combined company will focus on the cardiac electrophysiology market and is expected to close before the end of 2022, subject to shareholder approval and other customary closing conditions.

  • Buyer
    Ampersand Capital Partners
    Target
    Sterling Medical Devices
    Industry
    Medical Devices

    Ampersand Capital Partners, a healthcare-focused private equity firm, made a growth equity investment in Sterling Medical Devices, a Moonachie, New Jersey-based provider of design, development and regulatory services for the medical device industry. The investment is intended to support Sterling’s continued growth and capability expansion across product development, software/electromechanical integration, and regulatory affairs.

  • Buyer
    Tightrope Capital Partners, NewSpring Mezzanine (NewSpring Capital)
    Target
    VCI Emergency Vehicle Specialists
    Industry
    Medical Devices

    Tightrope Capital Partners has formed a new partnership with the management team of VCI Emergency Vehicle Specialists, with subordinated debt and equity provided by NewSpring Mezzanine to support the transaction. VCI, which operates four locations across New Jersey, Pennsylvania and New York selling and servicing new and used ambulances and performing remounts/conversions, will pursue geographic expansion and potential add-on acquisitions under the new partnership.

  • Buyer
    Aterian Investment Partners
    Target
    Allentown, LLC
    Seller
    Heartwood Partners Fund III, LP
    Industry
    Medical Devices
    Type
    Buyout

    Aterian Investment Partners has acquired a majority interest in Allentown, LLC, a 50+-year provider of vivarium laboratory equipment and solutions based in Allentown, New Jersey. The transaction — Aterian’s first investment from its Fund IV — was completed from Heartwood Partners (Heartwood Partners Fund III, LP), with Aterian positioning Allentown as a platform for further organic growth and M&A in the life‑sciences equipment/manufacturing space.

  • Buyer
    Corza Medical, GTCR
    Target
    Katena Products
    Seller
    Audax Private Equity
    Industry
    Medical Devices
    Type
    Addon

    Corza Medical, a GTCR portfolio company, has acquired Katena Products from Audax Private Equity. Katena is a Parsippany, New Jersey–based manufacturer of precision ophthalmic instruments, single-use devices and specialty biologics with more than 200 employees and sales in over 110 countries. Audax, which acquired Katena in 2015, supported the company's operational and M&A-driven growth during its ownership.

  • Buyer
    BioCheck, Inc.
    Target
    DRG International, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    BioCheck, Inc. has acquired DRG International, Inc., a manufacturer of clinical diagnostic ELISAs and the DRG:HYBRiD-XL automated analyzer. The deal combines BioCheck's chemiluminescent assay development and automation platform with DRG's R&D, manufacturing and global distribution network to accelerate development and global scale-up of advanced clinical and research diagnostic tests.

  • Buyer
    DCN Dx
    Target
    PortaScience, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    DCN Dx, a Carlsbad, California-based developer of point-of-care diagnostics, has completed the acquisition of PortaScience, Inc., a dry-chemistry focused point-of-care diagnostics development company based in Moorestown, New Jersey. The deal adds PortaScience's PortaCheck animal-health product line and expands DCN Dx's assay development, engineering, and product portfolio for healthcare, veterinary, and consumer diagnostics.

  • Buyer
    Paragon 28, Inc.
    Target
    Additive Orthopaedics
    Seller
    Additive Orthopaedics
    Industry
    Medical Devices

    Paragon 28, Inc. acquired the product lines and related assets of Additive Orthopaedics, including the FDA‑cleared 3D‑printed patient‑specific talus spacer and an integrated cloud‑based pre‑operative surgical planning application. The acquisition expands Paragon 28’s foot‑and‑ankle product offering and accelerates its strategy to integrate smart tools, AI and advanced technologies to improve patient outcomes.

  • Buyer
    Ott Scientific
    Target
    American Bionostica, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    Ott Scientific has acquired American Bionostica, Inc., a developer and manufacturer of specialty lateral flow assays; the acquisition was effective April 1 and ABI will operate inside Ott Scientific’s Ethos Biosciences subsidiary. The American Bionostica team will join Ott Scientific, with expanded research and production capacity planned at Ott Scientific’s new ISO13485/cGMP space in Logan Township, New Jersey.

  • Buyer
    Mettler-Toledo International Inc.
    Target
    PendoTECH
    Industry
    Medical Devices
    Type
    Buyout

    Mettler-Toledo International Inc. completed the acquisition of PendoTECH, a Princeton, New Jersey–based maker of single-use sensors, transmitters, control systems and software for bioprocess measurement and monitoring. The transaction includes $185 million initial consideration plus up to $20 million in contingent payments and is intended to expand Mettler-Toledo's process-analytics and sensor offerings for the bioprocessing market and enable cross-selling and broader global reach.

  • Buyer
    SteriPack Group
    Target
    HS Design Inc.
    Industry
    Medical Devices
    Type
    Buyout

    SteriPack Group acquired Morristown, New Jersey-based HS Design Inc., an ISO 13485 certified product development and industrial design firm focused on medical devices. The acquisition expands SteriPack's U.S. operations and brings design, human factors, and front-end product development capabilities into its contract manufacturing and lifecycle services offering.

  • Buyer
    STERIS plc
    Target
    Cantel Medical Corp.
    Seller
    Cantel common stockholders, Charles M. Diker and affiliated entities (voting support agreement)
    Industry
    Medical Devices
    Type
    Buyout

    STERIS plc agreed to acquire Cantel Medical Corp. in a cash-and-stock transaction valuing Cantel at approximately $3.6 billion equity ($4.6 billion enterprise), paying $84.66 per Cantel share. The deal expands STERIS’s infection‑prevention and endoscopy capabilities and extends the company into dental customers, with expected pre‑tax cost synergies of ~$110 million by year four and accretion to adjusted EPS in year one.

  • Buyer
    Zimmer Biomet
    Target
    A&E Medical Corporation
    Seller
    Vance Street Capital LLC, Wojciechowicz family
    Industry
    Medical Devices
    Type
    Buyout

    Zimmer Biomet completed the acquisition of A&E Medical Corporation from private equity owner Vance Street Capital for $250 million. A&E Medical, headquartered in Farmingdale, New Jersey, is a designer and manufacturer of sternal closure systems, cardiac pacing wires and related disposable surgical products; the deal expands Zimmer Biomet's capabilities and product portfolio in cardiovascular and cardiothoracic surgical devices.

  • Buyer
    Vance Street Capital LLC
    Target
    Wytech Industries Inc.
    Seller
    Casalino family
    Industry
    Medical Devices
    Type
    Buyout

    Los Angeles-based private equity firm Vance Street Capital acquired Wytech Industries, a Rahway, New Jersey manufacturer of specialty core wires and precision tube-based components for interventional medical devices. The Casalino family (founders) retain an ownership stake alongside Vance Street; terms were not disclosed. The deal represents Vance Street's first platform investment from Fund III and a strategic entry into a medical-device component manufacturing platform.

  • Buyer
    The Zabel Companies
    Target
    Medical Packaging Incorporated
    Industry
    Medical Devices
    Type
    Buyout

    The Zabel Companies has acquired Medical Packaging Incorporated (MPI), a Flemington, New Jersey-based provider of unit dose medication and pharmaceutical packaging systems, equipment, labeling software and consumables. The transaction was completed in partnership with MPI President/CEO Andy Bartels and is intended to provide additional resources to accelerate the company's growth.

  • Buyer
    LeMaitre Vascular, Inc.
    Target
    Artegraft, Inc.
    Seller
    Artegraft, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    LeMaitre Vascular, Inc. acquired the business and assets of Artegraft, Inc. for $90.0 million (including $72.5 million at closing and up to $17.5 million in earnouts). The acquisition adds Artegraft's biologic vascular graft product line (used primarily for hemodialysis access) to LeMaitre's portfolio and will keep Artegraft's North Brunswick, New Jersey manufacturing facility and most employees in place.

  • Buyer
    Safeguard Medical, Water Street Healthcare Partners
    Target
    Water-Jel Technologies
    Industry
    Medical Devices
    Type
    Addon

    Safeguard Medical, a Water Street Healthcare Partners–backed provider of first-responder medical products, has acquired Water-Jel Technologies, a Carlstadt, New Jersey–based leader in emergency burn care products. The deal expands Safeguard Medical's product portfolio, kitting and training capabilities and adds an FDA-registered, ISO-certified manufacturing facility; financial terms were not disclosed.

  • Buyer
    Capital Partners (Capital Partners Private Equity Income Fund III, LP)
    Target
    Allentown, Inc.
    Industry
    Medical Devices

    Capital Partners (through Capital Partners Private Equity Income Fund III, LP) completed a growth investment in Allentown, Inc. on October 22, 2019. John Coiro will remain CEO and Chairman as the investment is intended to support Allentown’s continued organic growth and acquisition-driven expansion of its lab animal housing and life‑science product offerings.

  • Buyer
    Linden Capital Partners
    Target
    Collagen Matrix, Inc.
    Seller
    Metalmark Capital
    Industry
    Medical Devices
    Type
    Buyout

    Linden Capital Partners, a Chicago-based healthcare private equity firm, has acquired Collagen Matrix, Inc., a New Jersey-based developer and manufacturer of collagen-based medical products used in tissue and bone repair across orthopedic, sports medicine, dental, and neurosurgery markets. The transaction (financing provided by Golub Capital and Northwestern Mutual) supports Linden's focus on medical products, contract/private-label manufacturing and expansion in dental and orthopedic end markets; Metalmark Capital was the prior owner.

  • Buyer
    EPTAM Precision Solutions, New Heritage Capital
    Target
    Micro Molding Inc. / MedConnection LLC
    Industry
    Medical Devices
    Type
    Addon

    EPTAM Precision Solutions, a portfolio company of New Heritage Capital, has acquired Micro Molding Inc. and MedConnection LLC, a Phillipsburg, New Jersey-based provider of precision plastic injection molding and catheter tipping solutions. The add-on broadens EPTAM's plastic injection molding capabilities to create a one-stop-shop for precision plastic and metal components serving medical device, aerospace & defense, and semiconductor customers.

  • Buyer
    Whitestone Corporation
    Target
    Humanicare International, Inc.
    Industry
    Medical Devices
    Type
    Buyout

    Whitestone Corporation has acquired Humanicare International to create a leading provider of adult incontinence care products, combining Whitestone’s long-term care focus with Humanicare’s strength in the home healthcare market. The deal brings together several market-leading brands (including Dignity, Compose, Ultrashield and Disposeze) to expand distribution, product capabilities and presence across long-term and home healthcare channels; terms were not disclosed.

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.

Frequently Asked Questions

What kinds of medical device acquisition themes show up in New Jersey?

Common themes include add-ons to existing platforms (expanding product capabilities and manufacturing or distribution) and carve-out transactions intended to position a business as a standalone platform.

Are there sterilization- and workflow-focused deals tied to New Jersey?

Yes. Examples include Allentown, LLC acquiring ClorDiSys Solutions, Inc. (chlorine dioxide-based sterilization equipment and contract sterilization services) and Straits Orthopaedics acquiring Medin Technologies, Inc. (sterilization cases and trays).

Which buyers appear more than once across these transactions?

Several buyers recur in the listed deals, including Aterian Investment Partners, ARCH Medical Solutions Corp. (and The Jordan Company), HuFriedyGroup (via Peak Rock Capital), Pharos Capital Group, LLC, and The Zabel Companies.

Do these acquisitions generally stay within New Jersey?

Many transactions reference New Jersey facilities or headquartered targets, but deal narratives also include broader U.S. operations or global manufacturing/customer reach (for example, facilities outside NJ or customers worldwide, depending on the buyer/target).

Related Acquisition Pages